NFKB1 and osteosarcoma: In addition, a number of studies have reported that metformin could downregulate RAGE expression and reduce NF-κB activation in various cells, including osteoblastic cells [68–70], MCF-7, MDA-MB-231 cells [71], and osteosarcoma stem cells [72].